Overview

Switching to Iloperidone From Other Antipsychotics in Schizophrenia

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
Evaluate the clinical outcome of two switching strategies to iloperidone treatment in adult subjects with schizophrenia who require a change in their current antipsychotic treatment of risperidone, olanzapine, or aripiprazole due to suboptimal efficacy and/or safety/tolerability reasons.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Aripiprazole
Iloperidone
Olanzapine
Risperidone